T1-weighted and flow-attenuated inversion recovery MRI of the brain revealed ... showing multiple punctate lesions (white arrows) in the basal ganglia and in the white matter of both cerebral ...

However, methods such as functional MRI should be used with extreme caution ... especially as it lies outside the basal ganglia and has no dopaminergic pathways 71. Taken together, these studies ...

Among the 28 selected subjects (mean age 69,85 ± 12 years, range 51–93; 11 women, 11 men and 6 not specified, 14 lesions were documented with original CT scans, 6 lesions with original MRI ... regions ...

MRI images were acquired on a 3.0 T Prisma MRI scanner ... and cognition in different side-lesion strokes (left or right basal ganglia infarcts), due to the small sample size, which may provide a more ...

"Our data also show that short term administration of a Survivin inhibitor leads to shrinkage and elimination of preneoplastic lesions and prevents basal cell carcinoma progression," the ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically.

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

ABSTRACT: Introduction: Biotin-thiamine-responsive basal ganglia disease (BTBGD) is a neuroregressive disorder associated with subacute encephalopathy, confusion, dysarthria, and dysphagia, as well as ...

Loading Twitter content On Saturday, Djokovic posted a photo of an MRI scan, accompanied by the comment: "Thought I'd leave this here for all the sports injury 'experts' out there." The 37-year ...

ABSTRACT: Introduction: Biotin-thiamine-responsive basal ganglia disease (BTBGD) is a neuroregressive disorder associated with subacute encephalopathy, confusion, dysarthria, and dysphagia, as well as ...

The aim of our study was to evaluate the efficacy and long-term results of interferon a-2a (IFNa-2a) in the treatment of basal cell carcinoma. Results: Eleven lesions (55%) showed complete ...

Eight weeks after completion of the therapy, 11 lesions (55%) clinically showed complete remission, six lesions (30%) showed partial remission, and two lesions (10%) showed no response.